Celon Pharma S.A. (CLN.WA)

PLN 23.85

(-7.38%)

Net Income Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual net income in 2023 was -28.12 Million PLN , up 28.4% from previous year.
Celon Pharma S.A.'s latest quarterly net income in 2024 Q2 was -8.02 Million PLN , up 48.79% from previous quarter.
Celon Pharma S.A. reported an annual net income of -39.27 Million PLN in 2022, down -238.39% from previous year.
Celon Pharma S.A. reported an annual net income of -11.6 Million PLN in 2021, down -154.0% from previous year.
Celon Pharma S.A. reported a quarterly net income of -8.02 Million PLN for 2024 Q2, up 48.79% from previous quarter.
Celon Pharma S.A. reported a quarterly net income of -6.81 Million PLN for 2023 Q3, down -174.54% from previous quarter.

Annual Net Income Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Net Income of Celon Pharma S.A. (2023 - 2012)

Year	Net Income	Net Income Growth
2023	-28.12 Million PLN	28.4%
2022	-39.27 Million PLN	-238.39%
2021	-11.6 Million PLN	-154.0%
2020	21.49 Million PLN	80.1%
2019	11.93 Million PLN	-59.81%
2018	29.69 Million PLN	15.93%
2017	25.61 Million PLN	-32.25%
2016	37.8 Million PLN	1.69%
2015	37.18 Million PLN	-28.78%
2014	52.2 Million PLN	190.72%
2013	17.95 Million PLN	1246.65%
2012	1.33 Million PLN	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-15.67 Million PLN	-4.69%
2024 Q2	-8.02 Million PLN	48.79%
2023 Q3	-6.81 Million PLN	-174.54%
2023 Q1	-9.47 Million PLN	20.94%
2023 FY	-28.12 Million PLN	28.4%
2023 Q2	9.14 Million PLN	196.5%
2023 Q4	-14.96 Million PLN	-119.65%
2022 Q2	-8.11 Million PLN	-7.96%
2022 Q1	-7.51 Million PLN	-84.16%
2022 FY	-39.27 Million PLN	-238.39%
2022 Q4	-11.98 Million PLN	-2.71%
2022 Q3	-11.66 Million PLN	-43.88%
2021 Q3	-7.83 Million PLN	-488.25%
2021 FY	-11.6 Million PLN	-154.0%
2021 Q4	-4.07 Million PLN	47.91%
2021 Q1	-1.71 Million PLN	46.87%
2021 Q2	2.01 Million PLN	217.61%
2020 Q2	3.46 Million PLN	-63.24%
2020 Q1	9.41 Million PLN	473.45%
2020 Q4	-3.22 Million PLN	-181.4%
2020 FY	21.49 Million PLN	80.1%
2020 Q3	3.96 Million PLN	14.6%
2019 Q3	2.13 Million PLN	27.71%
2019 Q1	6.49 Million PLN	3.55%
2019 Q2	1.67 Million PLN	-74.27%
2019 FY	11.93 Million PLN	-59.81%
2019 Q4	1.64 Million PLN	-23.04%
2018 Q3	8.29 Million PLN	9.26%
2018 Q2	7.58 Million PLN	0.51%
2018 Q1	7.54 Million PLN	20.92%
2018 Q4	6.26 Million PLN	-24.41%
2018 FY	29.69 Million PLN	15.93%
2017 Q4	6.24 Million PLN	26.79%
2017 Q3	4.92 Million PLN	-41.45%
2017 FY	25.61 Million PLN	-32.25%
2017 Q2	8.41 Million PLN	67.49%
2017 Q1	5.02 Million PLN	83.72%
2016 Q2	7.25 Million PLN	-53.13%
2016 FY	37.8 Million PLN	1.69%
2016 Q4	2.73 Million PLN	-62.04%
2016 Q1	15.47 Million PLN	112.64%
2016 Q3	7.2 Million PLN	-0.73%
2015 Q4	7.27 Million PLN	78.16%
2015 FY	37.18 Million PLN	-28.78%
2015 Q3	4.08 Million PLN	0.0%
2014 FY	52.2 Million PLN	190.72%
2013 FY	17.95 Million PLN	1246.65%
2012 FY	1.33 Million PLN	0.0%

Peer Net Income Comparison of Celon Pharma S.A.

Name	Net Income	Net Income Difference